A reversible generalized movement disorder in critically ill children with cancer

Neurocritical Care

Volumn 3, Issue 2, 2005, Pages 146-149

  Khan, Raja B ^a   Schmidt, Jeffrey E ^a   Tamburro, Robert F ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Cancer; Critically ill; Movement disorder

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; MIDAZOLAM; MORPHINE; OPIATE; PLATINUM DERIVATIVE;

ARTICLE; BRAIN CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; CRITICAL ILLNESS; ELECTROENCEPHALOGRAM; FEMALE; FIXATION FAILURE; HUMAN; INTENSIVE CARE UNIT; JAW MOVEMENT; MALE; MOTOR DYSFUNCTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SEDATION; SEIZURE; TONGUE;

BRAIN DISEASES; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; DYSTONIC DISORDERS; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INFANT; MALE; MIDAZOLAM; MOVEMENT DISORDERS; POSTURE;

EID: 24944478999     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1385/NCC:3:2:146     Document Type: Article

References (12)

1. Potter JM, Reid DB, Shaw RJ, Hackett P, Hickman PE. Myoclonus associated with treatment with high doses of morphine: the role of supplemental drugs. BMJ 1989;299:150-153.
2. Bergman I, Steeves M, Burckart G, Thompson A. Reversible neurologic abnormalities associated with prolonged intravenous midazolam and fentanyl administration. J Pediatr 1991;119:644-649.
3. Mott SH, Packer RJ, Vezina LG, et al. Encephalopathy with parkinsonian features in children following bone marrow transplantations and high-dose amphotericin B. Ann Neurol 1995;37:810-814.
4. Langston JW, Ballard PA, Jr. Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. N Engl J Med 1983;309:310.
5. Kostic VS, Stojanovic-Svetel M, Kacar A. Symptomatic dystonias associated with structural brain lesions: report of 16 cases. Can J Neurol Sci 1996;23:53-56.
6. Lane JC, Tennison MB, Lawless ST, Greenwood RS, Zaritsky AL. Movement disorder after withdrawal of fentanyl infusion. J Pediatr 1991;119:649-651.
7. Petzinger G, Mayer SA, Przedborski S. Fentanyl-induced dyskinesias. Mov Disord 1995;10:679-680.
8. Cadoni C, Di Chiara G. Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine. Neuroscience 1999;90:447-455.
9. Takada K, Murai T, Kanayama T, Koshikawa N. Effects of midazolam and flunitrazepam on the release of dopamine from rat striatum measured by in vivo microdialysis. Br J Anaesth 1993;70:181-185.
10. Schrater PR, Russo AC, Stanton TL, Newman JR, Rodriguez LM, Beckman AL. Changes in striatal dopamine metabolism during the development of morphine physical dependence in rats: observations using in vivo microdialysis. Life Sci 1993;52:1535-1545.
11. Zetterstrom T, Sharp T, Ungerstedt U. Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis. Eur J Pharmacol 1984;106:27-37.
12. Shafer A. Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens. Crit Care Med 1998;26:947-956.